Type
|
Public |
---|---|
Traded as | NASDAQ: ATHN |
Industry | Healthcare Technology |
Founded | 1997 |
Founders | Jonathan Bush Chief Executive Officer Todd Park Former Chief Technology Officer of the United States, |
Headquarters | Watertown, Massachusetts |
Products | athenaCollector (revenue cycle management, medical billing), athenaClinicals (electronic health records), athenaCommunicator (patient engagement, care coordination), Epocrates, and athenahealth Population Health (population health management) |
Revenue | US$100.8 million (2007), $1.08 billion (December, 2016) |
Number of employees
|
5,528 (as of June 2017) |
Website | athenahealth.com |
athenahealth, Inc. is a publicly traded American company that provides network-enabled services for healthcare and point-of-care mobile apps to drive clinical and financial results for its hospital and ambulatory clients in the United States. athenahealth has a network of more than 100,000 providers and 98 million patients and offers a suite of services to manage medical records, revenue cycle, patient engagement, care coordination, and population health.
The company was founded in 1997 in San Diego, California; it is now headquartered in Watertown, Massachusetts and has grown to include operational sites in Belfast, Maine; Atlanta, Georgia; Austin, Texas; Princeton, New Jersey; and Chennai, Bangalore, and Pune, India.
athenahealth began in 1997 as Athena Women's Health, a women's health and birthing center in San Diego, California. Cofounders Jonathan Bush and Todd Park set out to create a comfortable and comprehensive center, where mothers could receive "a warm and supportive environment, personal attention, better care, and superior results" while the back-end business was "a ruthlessly efficient operation, with a laser focus on costs."
The birthing center excelled at delivering healthy babies: Only 10% of babies were delivered by C-section, one third of the national average, and 90% of mothers were able to breastfeed their newborns, beating the national average of 67% at the time. Yet while quality increased, costs followed in suit, and Bush and Park eventually closed their birthing center and started a medical data company called athenahealth on the heels of the Internet boom of 1999.
In 1998, venture funder Mark Wilson offered to buy athenahealth’s software for $11 million. Bush and Park turned down the offer but followed Wilson’s instinct, transitioning from a business model from birthing centers to a vision of building the healthcare internet. They transformed Athena Women’s Health to athenahealth, Inc., pulling in Ed Park, Park’s younger brother and engineer, to develop a practice management system. Leaving clinical work in the hands of capable providers, their new business endeavor aimed to “let doctors be doctors” and remove incessant and burdensome paperwork off doctors’ desks.
The start of 2000 saw two important moments in time: athenahealth’s first client, Anchor Medical Associates, went live on athenaCollector; and in February, its first electronic claim was submitted. While its first office opened its doors in Waltham, Massachusetts in 2002, athenahealth moved to Watertown, Massachusetts in 2005 and is still headquartered there today.
athenahealth announced an initial public offering of its common stock on June 22, 2007. The offering was completed on September 20, 2007, at a price of $18 per share. It trades on the NASDAQ exchange under the symbol ATHN.
Since moving its headquarters to Watertown in 2005, athenahealth has created campuses in: Chennai, India, in 2005; Belfast, Maine, in 2008; Princeton, New Jersey, in 2013; Atlanta, Georgia, and San Francisco, California, in 2014; Austin, Texas, in 2015; and Bangalore and Pune, India, in 2017.
athenaOne is athenahealth's fully integrated suite of cloud-based services, combining practice management (athenaCollector), an electronic health record (EHR) system (athenaClinicals), and care coordination (athenaCommunicator) into a single packaged offering.
athenahealth’s first product, athenaCollector, a cloud-based revenue cycle and practice management service, rolled out in 2000. Built by Ed Park, the revenue cycle management system formed the foundation of athenaNet, athenahealth’s web-based system at large. (Ed Park would go on to become athenahealth’s Chief Operating Officer and member of its board.)
In 2006, the company launched athenaClinicals, reported as the "first economically sustainable, service-based" electronic medical records (EMR) system. athenaClinicals has been ranked as leading the market in EHR usability, due to its productivity and ability to reduce providers’ work, effectiveness of delivering patient care, and intuitive user interface.
In 2008, athenahealth introduced athenaCommunicator to manage phone calls. Since then, the product has evolved into a suite of "patient engagement services," including a patient portal, patient self-scheduling solution, and live operator service to better help patients to schedule appointments, reschedule appointments, and make payments.
In 2013, the company purchased the Epocrates mobile brand, and continued to occupy Epocrates’s offices in Princeton, New Jersey and San Francisco, California. As an athenahealth service, Epocrates aggregates treatment information, including dosing and contraindications, to provide clinical decision support in the prescribing moments of care.
Epocrates drug monographs have also been embedded into the athenaClinicals EHR system to enhance productivity and reduce time not spent on patients.
athenahealth's More Disruption Please (MDP) program was launched in 2011. The initiative is both a partner program and an incubator environment for independent companies to develop products and services connected to athenahealth's ecosystem.
In 2014, athenahealth created the More Disruption Please accelerator, an opportunity for young startups still finding their legs to begin developing in athenahealth’s MDP space. “The goal of [the MDP accelerator] is to lower the barrier of entry for the best solutions to help us build the healthcare Internet,” said Mandira Singh, director of the More Disruption Please program. In its first full year, the accelerator added five companies to its portfolio.
athenahealth launched MDP Labs in 2017. The program invites all entrepreneurs, from fledgling startups to mature companies, to innovate in healthcare and fix what’s broken. athenahealth’s MDP Labs offers workspace in its downtown San Francisco office, tailored programming, dedicated mentorship, opportunities for partnerships and funding, and exposure to potential clients.
In January 2015, athenahealth announced the acquisition of RazorInsights, a "leader in cloud-based EHR and financial solutions" for rural, critical access, and community hospitals. The purchase extended athenahealth’s established position in the outpatient market into the 50-bed and under inpatient care environment, which makes up nearly one third of the hospital market.
In February 2015, athenahealth announced that it had purchased webOMR, the web-based clinical applications and EHR platform developed by Boston’s Beth Israel Deaconess Medical Center. athenahealth collaborated with BIDMC on the development of athenahealth's acute care service offering, using Beth Israel Deaconess Hospital-Needham, a 58-bed community hospital, as the alpha development site.
athenahealth announced its acquisition of Praxify Technologies in June 2017. Praxify’s platform strategy and mobile capabilities enable seamless workflows and communication at moments of care, and its technology will be integrated into athenahealth’s cloud-based platform, allowing for meaningful collaborations between developers on forthcoming applications.
2016-06-29 | Reiterated Rating | Canaccord Genuity | Hold | $142.00 |
2016-06-16 | Reiterated Rating | Leerink Swann | Hold | |
2016-05-22 | Reiterated Rating | Deutsche Bank | Buy | $165.00 |
2016-05-22 | Reiterated Rating | KeyBanc | Hold | |
2016-05-22 | Reiterated Rating | KeyCorp | Hold | |
2016-05-22 | Reiterated Rating | Deutsche Bank AG | Buy | $165.00 |
2016-05-17 | Reiterated Rating | Piper Jaffray | Overweight | $174.00 |
2016-05-17 | Reiterated Rating | Piper Jaffray Cos. | Overweight | $174.00 |
2016-05-03 | Reiterated Rating | Leerink Swann | Hold | |
2016-05-02 | Reiterated Rating | JPMorgan Chase & Co. | Buy | $170.00 |
2016-04-26 | Reiterated Rating | Robert W. Baird | Buy | |
2016-04-25 | Reiterated Rating | Oppenheimer | Buy | |
2016-04-25 | Reiterated Rating | Oppenheimer Holdings Inc. | Buy | |
2016-04-17 | Reiterated Rating | Deutsche Bank | Buy | |
2016-04-15 | Reiterated Rating | FBR & Co. | Hold | |
2016-04-15 | Reiterated Rating | FBR & Co | Hold | |
2016-04-14 | Reiterated Rating | Leerink Swann | Hold | |
2016-04-05 | Reiterated Rating | Deutsche Bank | Buy | |
2016-02-08 | Upgrade | Topeka Capital Markets | Hold to Buy | $169.00 to $160.00 |
2016-02-08 | Lower Price Target | Leerink Swann | Market Perform | $175.00 to $150.00 |
2016-02-08 | Lower Price Target | Goldman Sachs | Neutral | $155.00 to $149.00 |
2016-02-08 | Lower Price Target | Goldman Sachs Group Inc. | Neutral | $155.00 to $149.00 |
2016-02-05 | Reiterated Rating | Cowen and Company | Outperform | $174.00 to $162.00 |
2016-02-05 | Reiterated Rating | FBR & Co. | Hold | $135.00 |
2016-02-05 | Reiterated Rating | Canaccord Genuity | Hold | $140.00 |
2016-01-22 | Reiterated Rating | Canaccord Genuity | Hold | $140.00 |
2015-12-14 | Boost Price Target | Topeka Capital Markets | Hold | $164.00 to $169.00 |
2015-12-11 | Reiterated Rating | Barclays | Sell | $110.00 |
2015-12-11 | Boost Price Target | Leerink Swann | Market Perform | $165.00 to $175.00 |
2015-12-11 | Reiterated Rating | Canaccord Genuity | Hold | $140.00 |
2015-12-11 | Reiterated Rating | Barclays PLC | Sell | $110.00 |
2015-12-10 | Reiterated Rating | FBR & Co. | Market Perform | $135.00 |
2015-12-09 | Reiterated Rating | Deutsche Bank | Buy | |
2015-12-04 | Boost Price Target | Cowen and Company | Outperform | $165.00 to $174.00 |
2015-12-02 | Reiterated Rating | Jefferies Group | Sell | |
2015-12-02 | Reiterated Rating | Canaccord Genuity | Underperform to Hold | $105.00 to $105.00 |
2015-11-19 | Reiterated Rating | FBR & Co. | Market Perform | $135.00 |
2015-11-17 | Initiated Coverage | JPMorgan Chase & Co. | Overweight | $170.00 |
2015-11-17 | Downgrade | Barclays | Equal Weight to Underweight | $140.00 to $110.00 |
2015-10-26 | Reiterated Rating | Canaccord Genuity | Hold | $140.00 |
2015-10-26 | Boost Price Target | Barclays | Equal Weight | $120.00 to $140.00 |
2015-10-26 | Boost Price Target | Oppenheimer | Outperform | $168.00 to $185.00 |
2015-10-26 | Downgrade | Leerink Swann | Outperform to Market Perform | |
2015-10-26 | Reiterated Rating | Stifel Nicolaus | Buy | $180.00 to $190.00 |
2015-10-26 | Downgrade | Topeka Capital Markets | Buy to Hold | $153.00 to $164.00 |
2015-10-26 | Boost Price Target | RBC Capital | Underperform | $80.00 to $105.00 |
2015-10-26 | Boost Price Target | Royal Bank Of Canada | Underperform | $80.00 to $105.00 |
2015-10-25 | Reiterated Rating | Cowen and Company | Buy | $165.00 |
2015-10-23 | Upgrade | Raymond James | Market Perform to Outperform | $160.00 |
2015-10-23 | Upgrade | Raymond James Financial Inc. | Market Perform to Outperform | $160.00 |
2015-10-21 | Initiated Coverage | Avondale Partners | Market Perform | $175.00 |
2015-10-20 | Reiterated Rating | Piper Jaffray | Buy | |
2015-10-19 | Reiterated Rating | Canaccord Genuity | Buy | $125.00 |
2015-10-16 | Downgrade | Jefferies Group | Hold to Underperform | $125.00 to $105.00 |
2015-09-11 | Reiterated Rating | Piper Jaffray | Overweight | $173.00 |
2015-07-27 | Reiterated Rating | Topeka Capital Markets | Buy | $150.00 to $153.00 |
2015-07-23 | Reiterated Rating | Canaccord Genuity | Hold | $125.00 |
2015-07-16 | Initiated Coverage | Canaccord Genuity | Hold to Hold | $125.00 |
2015-07-15 | Reiterated Rating | Avondale Partners | Hold | $125.00 |
2015-07-02 | Reiterated Rating | Deutsche Bank | Buy | |
2015-06-18 | Initiated Coverage | Stephens | Outperform | $168.00 |
2015-06-17 | Initiated Coverage | Oppenheimer | Outperform | $168.00 |
2015-06-12 | Lower Price Target | Topeka Capital Markets | Buy | $152.00 to $150.00 |
2015-05-04 | Lower Price Target | Topeka Capital Markets | Buy | $164.00 to $152.00 |
2015-04-14 | Set Price Target | Jefferies Group | Hold | $145.00 |
2015-04-13 | Set Price Target | Leerink Swann | Buy | $180.00 |
2015-03-19 | Initiated Coverage | Robert W. Baird | Outperform | $165.00 |
2015-02-09 | Reiterated Rating | Morgan Stanley | Buy | |
2015-02-09 | Boost Price Target | Oppenheimer | Underperform | $90.00 to $94.00 |
2015-02-04 | Upgrade | Compass Point | Market Perform to Outperform | $134.00 to $172.00 |
2015-02-04 | Upgrade | Cowen and Company | Market Perform to Outperform | $134.00 to $172.00 |
2015-01-29 | Boost Price Target | Leerink Swann | Outperform | $150.00 to $165.00 |
2015-01-15 | Boost Price Target | Stifel Nicolaus | Buy | $155.00 to $180.00 |
2015-01-08 | Boost Price Target | JPMorgan Chase & Co. | Overweight | $165.00 to $170.00 |
2014-12-23 | Boost Price Target | Topeka Capital Markets | Buy | $137.00 to $164.00 |
2014-12-22 | Reiterated Rating | Piper Jaffray | Buy | |
2014-12-12 | Reiterated Rating | Citigroup Inc. | Buy | $180.00 to $175.00 |
2014-12-11 | Lower Price Target | FBR & Co. | Market Perform | $120.00 to $110.00 |
2014-12-10 | Reiterated Rating | Deutsche Bank | Buy | |
2014-12-09 | Lower Price Target | JPMorgan Chase & Co. | Overweight | $170.00 to $165.00 |
2014-11-20 | Downgrade | RBC Capital | Sector Perform to Underperform | $115.00 to $80.00 |
2014-10-21 | Reiterated | FBR Capital | Mkt Perform | $134 to $120 |
2014-10-21 | Lower Price Target | FBR & Co. | Market Perform | $134.00 to $120.00 |
2014-10-20 | Reiterated Rating | Barclays | Equal Weight | $128.00 to $120.00 |
2014-10-20 | Lower Price Target | RBC Capital | Sector Perform | $140.00 to $115.00 |
2014-10-17 | Lower Price Target | Topeka Capital Markets | Buy | $144.00 to $137.00 |
2014-07-21 | Lower Price Target | Topeka Capital Markets | Buy | $145.00 to $144.00 |
2014-07-21 | Reiterated Rating | Barclays | Equal Weight | $125.00 to $128.00 |
2014-07-21 | Reiterated Rating | JPMorgan Chase & Co. | Overweight | $185.00 to $170.00 |
2014-07-21 | Reiterated Rating | Citigroup Inc. | Buy | $200.00 to $180.00 |
2014-07-18 | Reiterated | ISI Group | Neutral | $137 to $130 |
2014-07-18 | Lower Price Target | Evercore ISI | Neutral | $137.00 to $130.00 |
2014-06-25 | Initiated Coverage | Stifel Nicolaus | Overweight | $192.00 |
2014-06-17 | Initiated | Stifel | Buy | $155 |
2014-06-17 | Initiated Coverage | Stifel Nicolaus | Buy | $155.00 |
2014-06-13 | Initiated | Topeka Capital Markets | Buy | $145 |
2014-06-12 | Initiated Coverage | Topeka Capital Markets | Buy | $145.00 |
2014-05-12 | Reiterated Rating | Morgan Stanley | Overweight | $192.00 |
2014-05-07 | Lower Price Target | Oppenheimer | Underperform | $120.00 to $90.00 |
2014-05-02 | Reiterated | ISI Group | Neutral | $159 to $138 |
2014-05-02 | Lower Price Target | Evercore ISI | Neutral | $159.00 to $138.00 |
2014-04-28 | Upgrade | Ned Davis Research | Sell to Neutral | |
2014-04-23 | Upgrade | Morgan Stanley | Equal Weight to Overweight | $133.00 to $192.00 |
2014-04-22 | Reiterated Rating | Citigroup Inc. | Buy | $200.00 |
2014-04-22 | Upgrade | SunTrust | Neutral to Buy | $170.00 |
2014-04-21 | Reiterated | ISI Group | Neutral | $163 to $159 |
2014-04-21 | Lower Price Target | Deutsche Bank | Buy | $224.00 to $182.00 |
2014-04-21 | Lower Price Target | B. Riley | Neutral | $150.00 |
2014-04-21 | Reiterated Rating | Morgan Stanley | Strong-Buy to Equal Weight | $133.00 |
2014-04-21 | Reiterated Rating | Cowen and Company | Market Perform | $186.00 to $182.00 |
2014-04-21 | Lower Price Target | RBC Capital | Sector Perform | $180.00 to $140.00 |
2014-04-21 | Boost Price Target | FBR & Co. | Market Perform | $115.00 to $125.00 |
2014-04-21 | Lower Price Target | Evercore ISI | Neutral | $163.00 to $159.00 |
2014-04-21 | Upgrade | Jefferies Group | Underperform to Hold | $135.00 to $145.00 |
2014-04-17 | Lower Price Target | Oppenheimer | $140.00 to $120.00 | |
2014-04-15 | Reiterated Rating | Raymond James | Market Perform | |
2014-03-25 | Initiated Coverage | SunTrust | Neutral | $170.00 |
2014-03-10 | Downgrade | Oppenheimer | Market Perform to Underperform | $140.00 |
2014-03-05 | Initiated Coverage | Barclays | Equal Weight | $185.00 |
2014-02-25 | Boost Price Target | Sterne Agee CRT | Buy | $192.00 to $236.00 |
2014-02-18 | Upgrade | Robert W. Baird | Neutral to Outperform | $135.00 to $255.00 |
2014-02-18 | Initiated Coverage | Citigroup Inc. | Buy | |
2014-02-13 | Initiated Coverage | RBC Capital | Sector Perform | $180.00 |
2014-02-13 | Upgrade | Cowen and Company | Underperform to Market Perform | $123.00 to $186.00 |
2014-02-10 | Reiterated Rating | Goldman Sachs | Neutral | |
2014-02-07 | Boost Price Target | Evercore ISI | $143.00 to $176.00 | |
2014-02-07 | Boost Price Target | Cowen and Company | $88.00 to $123.00 | |
2014-02-07 | Boost Price Target | Sterne Agee CRT | $179.00 to $192.00 | |
2013-12-13 | Reiterated | ISI Group | Neutral | $126 to $133 |
2013-12-13 | Upgrade | Raymond James | Outperform to Strong-Buy | $150.00 |
2013-12-13 | Upgrade | Leerink Swann | Market Perform to Outperform | $150.00 |
2013-12-13 | Boost Price Target | Evercore ISI | Neutral | $126.00 to $133.00 |
2013-12-12 | Reiterated | FBR Capital | Mkt Perform | $130 to $105 |
2013-12-12 | Lower Price Target | FBR & Co. | Market Perform | $130.00 to $105.00 |
2013-12-09 | Initiated Coverage | JPMorgan Chase & Co. | Underweight to Overweight | $155.00 |
2013-11-20 | Initiated Coverage | Deutsche Bank | Buy | $162.00 |
2013-10-31 | Initiated | FBR Capital | Mkt Perform | $130 |
2013-10-31 | Initiated Coverage | FBR & Co. | Market Perform | $130.00 |
2013-10-23 | Boost Price Target | Sterne Agee CRT | Hold | $179.00 |
2013-10-22 | Boost Price Target | B. Riley | Neutral | $106.00 to $130.00 |
2013-10-22 | Downgrade | Raymond James | Outperform to Market Perform | $120.00 |
2013-10-21 | Reiterated Rating | Piper Jaffray | Overweight | $123.00 to $181.00 |
2013-10-18 | Boost Price Target | Robert W. Baird | Neutral | $104.00 to $125.00 |
2013-10-18 | Reiterated Rating | Wells Fargo & Co. | Outperform | $160.00 |
2013-10-18 | Reiterated Rating | Jefferies Group | Underperform | $60.00 to $75.00 |
2013-10-18 | Upgrade | Sterne Agee CRT | Neutral to Buy | $116.00 to $132.00 |
2013-10-18 | Reiterated Rating | Wells Fargo | Outperform | $160.00 |
2013-10-14 | Reiterated | ISI Group | Neutral | $111 to $118 |
2013-10-14 | Boost Price Target | Evercore ISI | Neutral | $111.00 to $118.00 |
2013-09-24 | Downgrade | Leerink Swann | Outperform to Market Perform | $120.00 |
2013-02-08 | Reiterated | ISI Group | Neutral | $80 to $96 |
2012-03-15 | Downgrade | Auriga | Hold to Sell | |
2012-02-17 | Reiterated | Auriga | Hold | $47 to $57 |
2016-06-29 | Reiterated Rating | Canaccord Genuity | Hold | $142.00 |
2016-06-16 | Reiterated Rating | Leerink Swann | Hold | |
2016-05-22 | Reiterated Rating | Deutsche Bank | Buy | $165.00 |
2016-05-22 | Reiterated Rating | KeyBanc | Hold | |
2016-05-22 | Reiterated Rating | KeyCorp | Hold |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In ATHN 32 funds of 2213 total. Show all
Fund name | Ticker shares |
---|---|
JANUS CAPITAL MANAGEMENT LLC | 5.72M |
BlackRock Institutional Trust Company, N.A. | 1.04M |
EverPoint Asset Management, LLC | 0.42M |
BlackRock Fund Advisors | 0.41M |
MANAGED ACCOUNT ADVISORS LLC | 0.39M |
OTTER CREEK MANAGEMENT INC | 47000 |
BLACKROCK ADVISORS LLC | 34216 |
Placemark Investments, Inc. | 31978 |
BlackRock Group LTD | 31302 |
Chautauqua Capital Management | 19898 |
Spot Trading L.L.C | 19511 |
BlackRock Investment Management, LLC | 18735 |
Adamant Biomedical Investments AG | 10000 |
RUSSELL FRANK CO/ | 9338 |
BUSH ODONNELL INVESTMENT ADVISORS INC | 9256 |
Name Relationship | Total Shares | Holding stocks |
---|---|---|
Bush Jonathan CEO and President | 0.88% (335106) | ATHN / |
Adams Timothy M CFO & SVP | 0.10% (38185) | ATHN / DWRE / MODN / |
KAHANE STEPHEN N President, Enterprise Services | 0.09% (35278) | ATHN / |
Matus Kristi Ann EVP and CFAO | 0.09% (34531) | ATHN / |
LEVINE MARC A Chief Financial Officer | 0.08% (30411) | ATHN / HPQ / |
Orenstein Daniel H. SVP, GC, and Secretary | 0.08% (28631) | ATHN / |
Khot Prakash SVP, Chief Technology Officer | 0.07% (25149) | ATHN / |
Park Ed EVP and COO | 0.06% (22347) | ATHN / CSLT / |
Stubelis Karl VP and Corporate Controller | 0.05% (17858) | ATHN / SAPE / |
Porter Jonathan D. SVP, Network Services | 0.05% (17429) | ATHN / |
Ittycheria Dev | 0.04% (13438) | ATHN / BV / |
Haley Daniel P SVP, GC and Secretary | 0.03% (12583) | ATHN / |
Holman Diane SVP, Chief People Officer | 0.03% (12500) | ATHN / |
KANE JOHN A | 0.03% (12009) | ATHN / MBVT / |
KOSECOFF JACQUELINE B | 0.03% (10875) | ATHN / CFN / SEE / STE / |
Armbrester Bradford Kyle SVP, Chief Product Officer | 0.02% (9464) | ATHN / |
O'Brien Timothy John SVP, Chief Marketing Officer | 0.02% (8999) | ATHN / |
IMMELT JEFFREY R | 0.02% (7302) | ATHN / GE / |
Delinsky Jeremy SVP, Chief Product Officer | 0.02% (7053) | ATHN / W / |
MANN JAMES L | 0.02% (5710) | ATHN / SDS / |
Hull Brandon H | 0.01% (5230) | ATHN / |
Abernethy Amy | 0.01% (4045) | ATHN / |
ROBINSON DAVID ERIC | 0.01% (3596) | ATHN / |
SZKUTAK THOMAS J | 0.01% (3056) | AMZN / ATHN / INTU / |